November 10 2020
Biotechnology/Life Sciences/Pharmaceuticals, COVID-19, Manufacturing, Research & Development

The Research Connection – November, 2020: COVID-19 Edition

Featured university R&D projects: 30-Minute COVID-19 Antibody Test Unique System for Using UVC Light to Sterilize Masks in Bulk Diagnostic Saliva COVID-19 Test Rapid Corona Virus Testing Engineers Developing New Ways to Optimize N95 Masks COVID-19 Pooled Surveillance Testing Program Streamlined Temperature Screening System UB facilities used to develop COVID-19

October 13 2020
Advanced Materials, Nanotechnology, News, Research & Development

NY Capital Region Inventors Listed on 1,400+ Semiconductor Device Patents in 2019 – up 8%

FOR IMMEDIATE RELEASE More Semiconductor Innovation attributable to Capital Region than Any State except CA ALBANY, NEW YORK – As the semiconductor industry rallies to increase domestic chip production, Capital Region inventors are driving even more innovation to support that re-shoring movement. In 2019, the U.S. Patent and Trademark Office

August 11 2020
Biotechnology/Life Sciences/Pharmaceuticals, General, Research & Development

The Research Connection – August 2020: Cancer Research Edition

Featured R&D projects: Transfer RNAs in Cancer Improving Targeted Therapies against Solid Tumors Targeting the Chaperone of Kidney Cancer Choice of anesthesia may affect breast metastases New inhibitor shows promise against metastatic prostate cancer A Tumor Model that More Closely Mimics the Body Protein Linked to Cancer Acts as a

July 17 2020
Advanced Materials, Manufacturing, Nanotechnology, Research & Development

CEG Continues to Represent the Capital Region at SEMICON West – Now Virtually

Regional industry attraction efforts continue despite COVID-19 The coronavirus pandemic will not be stopping the Center for Economic Growth from promoting the Capital Region’s innovation assets and manufacturing capabilities at the nation’s leading semiconductor industry event. Except instead of traveling to San Francisco to attend the 50th annual SEMICON West,

May 5 2020
Biotechnology/Life Sciences/Pharmaceuticals, COVID-19, Research & Development

Capital Region Life Sciences Cluster Mobilizes to Counter COVID-19

From conducting clinical trials to developing testing equipment and medical devices, the Capital Region’s Life Sciences Cluster is contributing to the effort to fight the coronavirus pandemic. The Life Sciences Cluster employs more than 5,800 and features several industries that are nationally unique. Below is an overview of COVID-19-related activates

March 17 2020
Population Health Technology, Research & Development

The Research Connection – March 2020: Population Health Technology Edition

Featured R&D projects: MortalityMinder: A Tool for Analyzing County-level Mortality Trends App-Based Device to Accelerate Recovery for Chronic Pain, Other Illnesses Population Health Observatory This edition’s contributors: SUNY Research Foundation | University at Albany | University at Buffalo | Rensselaer Polytechnic Institute MortalityMinder: A Tool for Analyzing County-level Mortality Trends

January 9 2020
Biotechnology/Life Sciences/Pharmaceuticals, Research & Development

Capital Region NIH Awards Climb to 11-Year High

National Institutes of Health (NIH) awards in the Capital Region climbed to an 11-year high in fiscal 2019, driven by a surge in R&D funding at AMRI, GE Global Research, Rensselaer Polytechnic Institute (RPI) and Albany Medical Center, according to a Center for Economic Growth (CEG) analysis.1 “These NIH awards

December 10 2019
Research & Development, Software/Gaming/IT

The Research Connection – December 2019: Software Edition

Featured R&D projects: AiMOS – Artificial Intelligence Multiprocessing Optimized System A Self-Protecting 5G System Using Quantum Computing Approaches Improving Deepfake Detection Expanding Wireless Technology Where’s Waldo? Identifying Cyberattacks using Low-Level Hardware Information This edition’s contributors: SUNY Research Foundation | SUNY Polytechnic Institute | University at Albany | Clarkson University |

December 5 2019
Biotechnology/Life Sciences/Pharmaceuticals, Research & Development

Pharma Industry Funds 100s of Drug Clinical Trials in Capital Region

The pharmaceutical industry has started conducting hundreds of clinical trials at Capital Region medical facilities in recent years, and more drug testing is expected as the local Life Sciences Cluster vastly expands with several multimillion-dollar projects. Emerging Clinical Trial Support Assets The pharmaceutical industry funded 342 clinical trials for drug

December 5 2019
Biotechnology/Life Sciences/Pharmaceuticals, Research & Development

Capital Region Academic Life Sciences R&D Surges

R&D spending on life sciences increased by nearly 18 percent to $126.7 million in fiscal 2018. That was a four-year high for local R&D spending in that field, according to a Center for Economic Growth (CEG) analysis of new data from the Nation Center for Science and Engineering Statistics. The

Funding Partners